First Four Members Of US FDA’s Newest Advisory Committee Are Mostly Rookies

19 Jul 2024

• By Michael McCaughan

Most of the new Genetic Metabolic Diseases Advisory Committee members have little FDA or advisory committee experience, except the new industry representative, with six more voting slots still to fill before its first meeting.

new person — Three of the new GeMDAC members have never served on an FDA advisory committee. • Source: Shutterstock

First Four Members Of US FDA’s Newest Advisory Committee Are Mostly Rookies

More from Rare Diseases

More from Pink Sheet